首页> 美国卫生研究院文献>Cancer Science >Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing
【2h】

Small lung tumor biopsy samples are feasible for high quality targeted next generation sequencing

机译:小型肺肿瘤活检样品可用于高质量的靶向下一代测序

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Next‐generation sequencing (NGS) has been implemented in clinical oncology to analyze multiple genes and to guide therapy. In patients with advanced lung cancer, small biopsies such as computed tomography‐guided needle biopsy (CTNB), endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) and transbronchial biopsy (TBB) are less invasive and are preferable to resection to make a pathological diagnosis. However, the quality of DNA/RNA and NGS from small lung tumor biopsy samples is unknown. Between April 2017 and March 2018, 107 consecutive samples were obtained from thoracic tumors or metastatic sites for targeted NGS analysis. Fifteen samples were obtained through CTNB, 11 through EBUS‐TBNA, 11 through TBB and 70 through surgical resection. All samples were formalin‐fixed and paraffin‐embedded. DNA and RNA quality was measured using the ddCq method and the percentage of RNA fragments above 200 nucleotides ( style="fixed-case">DV200), respectively. Our custommade probes were designed to capture exon sequences of 464 cancer‐related genes and transcripts of 463 genes. style="fixed-case">DNA and style="fixed-case">RNA yield from the 3 biopsy methods were similar, and less than the yield obtained from resected samples. The quality of style="fixed-case">DNA and style="fixed-case">RNA was similar across all methods. Overall, 12 of 15 style="fixed-case">CTNB samples (80%), all 11 style="fixed-case">EBUS‐ style="fixed-case">TBNA samples, and 9 of 11 style="fixed-case">TBB samples (82%) underwent successful style="fixed-case">NGS assays from style="fixed-case">DNA. style="fixed-case">NGS analysis from style="fixed-case">RNA was successful in all 12 style="fixed-case">CTNB samples, 9 of 11 style="fixed-case">EBUS‐ style="fixed-case">TBNA samples (82%), and 8 of 11 style="fixed-case">TBB samples (73%). style="fixed-case">CTNB, style="fixed-case"> EBUS‐ style="fixed-case">TBNA and style="fixed-case">TBB mostly resulted in adequate style="fixed-case">DNA and style="fixed-case">RNA quality and enabled high‐quality targeted style="fixed-case">NGS analysis.
机译:下一代测序(NGS)已在临床肿瘤学中实施,以分析多个基因并指导治疗。在晚期肺癌患者中,小型活检(例如计算机断层扫描引导穿刺活检(CTNB),支气管内超声引导经支气管穿刺活检(EBUS-TBNA)和经支气管活检(TBB))的侵入性较小,因此首选切除术以病理诊断。但是,来自小型肺肿瘤活检样品的DNA / RNA和NGS的质量尚不清楚。在2017年4月至2018年3月之间,从胸腔肿瘤或转移部位获得了107个连续样本用于靶向NGS分析。通过CTNB获得了15个样本,通过EBUS-TBNA获得了11个样本,通过TBB获得了11个样本,通过手术切除获得了70个样本。所有样品均经过福尔马林固定和石蜡包埋。使用ddCq方法测量DNA和RNA的质量,分别测量200个核苷酸以上的RNA片段的百分比( style =“ fixed-case”> DV 200)。我们定制的探针旨在捕获464个与癌症相关的基因的外显子序列和463个基因的转录本。三种活检方法的 style =“ fixed-case”> DNA 和 style =“ fixed-case”> RNA 的产量相似,但低于从切除样品中获得的产量。在所有方法中, style =“ fixed-case”> DNA 和 style =“ fixed-case”> RNA 的质量在所有方法中都相似。总体而言,在15个 style =“ fixed-case”> CTNB 样本中有12个(占80%),全部11个 style =“ fixed-case”> EBUS - style =“ fixed -case“> TBNA 样本,并且11个 style =” fixed-case“> TBB 样本中有9个(82%)成功进行了 style =” fixed-case“> NGS DNA 的span>分析。 style =“ fixed-case”> RNA 中的 style =“ fixed-case”> NGS 分析在所有12个 style =“ fixed-case”> CTNB 中都是成功的样本,11个 style =“ fixed-case”> EBUS - style =“ fixed-case”> TBNA 样本中的9个(82%)和11个 style =“ fixed-case”> TBB 样本(73%)。 style =“ fixed-case”> CTNB , style =“ fixed-case”> EBUS - style =“ fixed-case”> TBNA 和 style =“ fixed-case”> TBB 主要导致足够的 style =“ fixed-case”> DNA 和 style =“ fixed-case”> RNA 质量和启用了高质量的有针对性的 style =“ fixed-case”> NGS 分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号